化学科研者一站式服务平台


  • (+)-JQ-1; (S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-6-基)乙酸叔丁酯

    (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate

化合物简介

JQ1 is a thienotriazolodiazepine and a potent inhibitor of the BET family of bromodomain proteins which include BRD2, BRD3, BRD4, and the testis-specific protein BRDT in mammals. BET inhibitors structurally similar to JQ1 are being tested in clinical trials for a variety of cancers including NUT midline carcinoma. It was developed by the James Bradner laboratory at Brigham and Women's Hospital and named after chemist Jun Qi. The chemical structure was inspired by patent of similar BET inhibitors by Mitsubishi Tanabe Pharma [WO/2009/084693]. Structurally it is related to benzodiazepines. While widely used in laboratory applications, JQ1 is not itself being used in human clinical trials because it has a short half life.

基本信息

CAS:1268524-70-4
中文别名
英文别名:UNII-1MRH0IMX0W;4flp;3mxf;
分子式:C23H25ClN4O2S
分子量:456.988
精确质量:456.139
Psa:97.61
Logp:4.9669

编号系统

UNII:1MRH0IMX0W

物化性质

密度:1.3±0.1g/cm3
沸点:610.4±65.0°Cat760mmHg
闪点:322.9±34.3°C
外观性状:whitetobeige
蒸汽压:0.0±1.7mmHgat25°C
折射率:1.657
储存条件:2-8°C
水溶解性:DMSO:soluble20mg/mL,clear

安全信息

生产方法及用途

合成路线

上游原料

下游产品

图谱

13C NMR : Predict


1H NMR : Predict


加载中...